Sanofi said the Food and Drug Administration has approved Sarclisa as a first line combined treatment option for adult patients with newly diagnosed multiple myeloma who aren't eligible for autologous ...
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater proportion ...
Sarclisa approved in the US as the first anti-CD38 therapy ... Drug Administration said on Friday it has approved the use of a drug combination along with Sanofi's Sarclisa infusion as a ...
Some results have been hidden because they may be inaccessible to you